Kura Oncology (KURA) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts KURA Hot Sheet
Join SI Premium – FREE
Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.49), $0.08 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Kura Oncology (KURA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance
- Salesforce (CRM) Tops Q2 EPS by $2.63, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
